These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24098449)

  • 21. Impact of multiresistance of gram-negative bacteria in bloodstream infection on mortality rates and length of stay.
    Sostarich AM; Zolldann D; Haefner H; Luetticken R; Schulze-Roebecke R; Lemmen SW
    Infection; 2008 Feb; 36(1):31-5. PubMed ID: 18231721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Incremental Delays in Appropriate Therapy on the Outcomes of Hospitalized Adult Patients with Gram-negative Bloodstream Infections: "Every day matters".
    Lodise TP; Kanakamedala H; Hsu WC; Cai B
    Pharmacotherapy; 2020 Sep; 40(9):889-901. PubMed ID: 33112456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology and outcomes of hospitalizations with complicated skin and skin-structure infections: implications of healthcare-associated infection risk factors.
    Zilberberg MD; Shorr AF; Micek ST; Hoban AP; Pham V; Doherty JA; Ramsey AM; Kollef MH
    Infect Control Hosp Epidemiol; 2009 Dec; 30(12):1203-10. PubMed ID: 19848604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gram-negative bacteraemia in non-ICU patients: factors associated with inadequate antibiotic therapy and impact on outcomes.
    Marschall J; Agniel D; Fraser VJ; Doherty J; Warren DK
    J Antimicrob Chemother; 2008 Jun; 61(6):1376-83. PubMed ID: 18344548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrent gram-negative bloodstream infection: a 10-year population-based cohort study.
    Al-Hasan MN; Eckel-Passow JE; Baddour LM
    J Infect; 2010 Jul; 61(1):28-33. PubMed ID: 20378069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association Between Infectious Diseases Consultation and Mortality in Hospitalized Patients With Gram-negative Bloodstream Infection: A Retrospective Population-wide Cohort Study.
    Ong SWX; Luo J; Fridman DJ; Lee SM; Johnstone J; Schwartz KL; Diong C; Patel SN; MacFadden DR; Langford BJ; Tong SYC; Brown KA; Daneman N
    Clin Infect Dis; 2024 Oct; 79(4):855-863. PubMed ID: 38758977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Derivation of a quick Pitt bacteremia score to predict mortality in patients with Gram-negative bloodstream infection.
    Battle SE; Augustine MR; Watson CM; Bookstaver PB; Kohn J; Owens WB; Baddour LM; Al-Hasan MN
    Infection; 2019 Aug; 47(4):571-578. PubMed ID: 30737765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pseudomonas aeruginosa bloodstream infections in children: a 9-year retrospective study.
    Pilmis B; Alby-Laurent F; Fasola ML; Seegers V; Guery R; Guet-Revillet H; Postaire M; Toubiana J; Bille E; Lortholary O; Zahar JR
    Eur J Pediatr; 2020 Aug; 179(8):1247-1254. PubMed ID: 32080759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal duration of antimicrobial therapy for uncomplicated Gram-negative bloodstream infections.
    Nelson AN; Justo JA; Bookstaver PB; Kohn J; Albrecht H; Al-Hasan MN
    Infection; 2017 Oct; 45(5):613-620. PubMed ID: 28478600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.
    Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM
    J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of oral antibiotics for definitive therapy of Gram-negative bloodstream infections.
    Kutob LF; Justo JA; Bookstaver PB; Kohn J; Albrecht H; Al-Hasan MN
    Int J Antimicrob Agents; 2016 Nov; 48(5):498-503. PubMed ID: 27590704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gram-negative bacteraemia; a multi-centre prospective evaluation of empiric antibiotic therapy and outcome in English acute hospitals.
    Fitzpatrick JM; Biswas JS; Edgeworth JD; Islam J; Jenkins N; Judge R; Lavery AJ; Melzer M; Morris-Jones S; Nsutebu EF; Peters J; Pillay DG; Pink F; Price JR; Scarborough M; Thwaites GE; Tilley R; Walker AS; Llewelyn MJ;
    Clin Microbiol Infect; 2016 Mar; 22(3):244-51. PubMed ID: 26577143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome.
    Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
    Antimicrob Agents Chemother; 2005 Feb; 49(2):760-6. PubMed ID: 15673761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic strategies and clinical outcomes for patients with carbapenem-resistant Gram-negative bacterial bloodstream infection.
    Qu J; Feng C; Li H; Lv X
    Int J Antimicrob Agents; 2021 Mar; 57(3):106284. PubMed ID: 33484833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inappropriate antibiotic therapy in Gram-negative sepsis increases hospital length of stay.
    Shorr AF; Micek ST; Welch EC; Doherty JA; Reichley RM; Kollef MH
    Crit Care Med; 2011 Jan; 39(1):46-51. PubMed ID: 20890186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extended-Infusion β-Lactam Therapy, Mortality, and Subsequent Antibiotic Resistance Among Hospitalized Adults With Gram-Negative Bloodstream Infections.
    Karaba SM; Cosgrove SE; Lee JH; Fiawoo S; Heil EL; Quartuccio KS; Shihadeh KC; Tamma PD
    JAMA Netw Open; 2024 Jul; 7(7):e2418234. PubMed ID: 38954416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nosocomial Gram-negative bacteremia in intensive care: epidemiology, antimicrobial susceptibilities, and outcomes.
    Sligl WI; Dragan T; Smith SW
    Int J Infect Dis; 2015 Aug; 37():129-34. PubMed ID: 26159847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic and therapeutic yield of imaging studies in Polymicrobial and Monomicrobial Gram-negative bloodstream infections - a retrospective cohort study.
    Massalha M; Mahamid L; Ishay L; Freimann S; Cohen R; Reisfeld S
    Diagn Microbiol Infect Dis; 2024 Sep; 110(1):116366. PubMed ID: 39002447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Delayed Appropriate Antibiotic Therapy on Patient Outcomes by Antibiotic Resistance Status From Serious Gram-negative Bacterial Infections.
    Bonine NG; Berger A; Altincatal A; Wang R; Bhagnani T; Gillard P; Lodise T
    Am J Med Sci; 2019 Feb; 357(2):103-110. PubMed ID: 30665490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors and outcomes for the acquisition of carbapenem-resistant Gram-negative bacillus bacteremia: A retrospective propensity-matched case control study.
    Ting SW; Lee CH; Liu JW
    J Microbiol Immunol Infect; 2018 Oct; 51(5):621-628. PubMed ID: 28732563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.